Multiple Sclerosis: Hope Through New Oral Therapeutics

Main Category: Multiple Sclerosis
Also Included In: Neurology / Neuroscience
Article Date: 23 Jun 2009 - 2:00 PDT

email to a friend

printer friendly

view / write opinions

rate article

Current Article Ratings:

Patient / Public:		3.38 (8 votes)
Health Professional:		2 (1 votes)
Article Opinions:	0 posts

multiple sclerosis. Currently available therapeutic remedies are not yet capable of sufficiently helping all the affected. Researchers around the globe are therefore working to expand the variety of therapies. At the current meeting of the European Neurological Society in Milan reports are being presented on a number of new orally administered substances whose latest trials have shown promising results. New insights are also being provided on MS rehabilitation and living quality of the affected.

"The immunomodulating and immunosuppressive therapies for multiple sclerosis available today are only partially effective. We need a better use of the existing therapies - inter alia through early treatment and innovative approaches - in order to more efficiently help our patients," says Professor Giancarlo Comi of Milan, Italy, Chairperson of the meeting of the European Neurological Society (ENS) currently held in his home town. This major meeting in European neurology gathers more than 2,900 experts from all over the world. Professor Comi: "One interesting development involves new drugs highly active that can be taken orally."

More than 400,000 people in Europe suffer from multiple sclerosis (MS), the most common neurological disease leading to permanent disability in young adults. MS attacks the central nervous system and is considered an auto-immune disease, but other possible causes are also under discussion. "Multiple sclerosis is still not curable. A number of new findings have been made in recent years with regard to the origins of the disease and new therapeutic strategies," says Professor Comi. "These new insights can help us to mitigate the course of the disease and delay the development of permanent disabilities. Moreover some new treatments which will be available soon will enhance the possibility to control the disease evolution, opening new positive perspectives for patients."

Source
European Neurological Society

Please rate this article:
(Hover over the stars
then click to rate)

Patient / Public:

Health Professional:

Multiple Sclerosis headlines

email to a friend

printer friendly version

weekly newsletter

daily news alerts

personalize your news

rss feeds

Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to front page

List of All Medical Articles